For years, the term Polycystic Ovary Syndrome (PCOS) has been widely used to describe one of the most common hormonal conditions affecting women of reproductive age. However, experts have long argued that the name was incomplete, even misleading. But, now, after a landmark global effort led by Monash University, PCOS will be called Polyendocrine Metabolic Ovarian Syndrome (PMOS), which better reflects the condition’s complex, multisystem nature. Dr Garima Kachchawa, professor, obstetrics and gynaecology, All India Institute of Medical Sciences (AIIMS) Delhi , explains the impact of the updated terminology . Speaking to The Indian Express , she says: “the shift also underlines the need for women and clinicians to look beyond reproductive symptoms and recognise the broader health risks linked to the disorder”.…